Life Sciences Quality Management Software Market Size, Share & Trends Analysis Report By Application (Data Management), By Deployment Mode (Web & Cloud-based, On-premise), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Life Sciences Quality Management Software Market Size, Share & Trends Analysis Report By Application (Data Management), By Deployment Mode (Web & Cloud-based, On-premise), By End Use, By Region, And Segment Forecasts, 2025 - 2030


Ophthalmic Drug Delivery Systems Market Growth & Trends

The global ophthalmic drug delivery systems market size is projected to reach USD 23.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2025 to 2030. Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market. In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers’ instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site.

The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient’s visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government’s initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.

Ophthalmic Drug Delivery Systems Market Report Highlights
  • The eye drops segment dominated the market with highest revenue share in 2024 as eye drops are often recommended as the first line of treatment in most of the ophthalmic procedures to control the effect of the disease as it is the most convenient and patient compliant technology.
  • The intraocular segment held the highest revenue share in 2024 owing to the advantages it offers such as sterilization, less irritation, ease of eye drops formulation and enhancement in ocular bioavailability of drugs that are insoluble in tear fluid.
  • On the basis of production technology, the formulation segment accounted for highest market share in 2024 owing to increase in adoption of topical eye drops which is produced through the formulation technology.
  • Based on material, the hydrogels segment held the highest market share in 2024 owing to the advantages it offers over other materials.
  • North America accounted for highest market share in 2024 due to increasing incidence of ophthalmic disorders, presence of skilled professionals and various initiatives undertaken by the government agencies to prevent blindness in the region.
  • The COVID-19 pandemic has a negative impact on the market. Due to change in healthcare priorities, social distancing, worldwide lockdowns led to reduced patient visits to the hospitals and clinics.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Application Segment
1.2.2. Deployment Mode
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
1.10.3. Objective 3
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Life Sciences Quality Management Software Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements in the life science industry
3.2.1.2. Growing need to comply with regulatory guidelines
3.2.1.3. Increasing use of quality management software (QMS) in the life sciences supply chain to ensure product quality and safety
3.2.2. Market restraint analysis
3.2.2.1. Security concerns with cloud deployment
3.2.2.2. A shortage of skilled professionals
3.3. Life Sciences Quality Management Software Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
Chapter 4. Life Sciences Quality Management Software Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Life Sciences Quality Management Software Market Application Movement Analysis
4.3. Global Life Sciences Quality Management Software Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Data Management
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Training Management
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Supplier Management
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Regulatory and Compliance Management
4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Corrective Action Preventive Action (CAPA) Management
4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Audit Management
4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Change Management
4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Non-conformances Management
4.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Inspection Management
4.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Risk Management
4.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Others
4.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Life Sciences Quality Management Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Life Sciences Quality Management Software Market Deployment Mode Movement Analysis
5.3. Global Life Sciences Quality Management Software Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
5.4. Cloud & Web-based
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. On-premises
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Life Sciences Quality Management Software Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Life Sciences Quality Management Software Market End Use Movement Analysis
6.3. Global Life Sciences Quality Management Software Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical Firms
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Biotech Firms
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. CROs/CDMOs
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Life Sciences Quality Management Software Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.2.1. Partnerships & collaborations
8.2.2. Mergers & acquisitions
8.2.3. New product launches
8.2.4. Expansions
8.2.5. Others
8.3. Company Market Position Analysis
8.4. Company Profiles/Listing
8.4.1. Dassault Systèmes
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. IQVIA (Pilgrim)
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. MasterControl Solutions, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. AmpleLogic
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Qualio - QMS for Life Sciences
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. QT9 Software
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Sparta Systems- TrackWise (Honeywell International Inc.)
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. AssurX, Inc
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. ETQ, LLC (Hexagon)
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Veeva Systems
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Qualityze
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Ideagen
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings